The problem isn’t legalization. It’s how we’ve chosen to legalize: by defaulting to a kind of Wild West capitalism that treats drugs like any other consumer product rather than as substances that carry real risks and deserve serious regulation. | Forefront
Scott Burris, et al. |
Health Affairs Publishing delivers rigorous, nonpartisan research and analysis to improve health and health care.
Follows/Tweets/RTs ≠ endorsements.
- Litigation should not be the strategy to achieve Star Rating reform. It is the alarm, not the repair. | Forefront @sacjai, et al. | @SCANHealthPlan
- Kirsten Axelsen @DLA_Piper breaks down the debate over whether Medicare drug price negotiations could discourage pharmaceutical companies from investing in new uses for existing medicines. healthaffairs.org/content/forefr…
- Chiles, read closely, says only that a state may not draw an explicit viewpoint line on the face of a licensure statute. Beyond that line, where licensure regimes condition credentials on the profession’s own standards of care, states retain their power. | Forefront Jennifer
- Jiebing Wen of @UTAustin & coauthors examine quality outcomes & Medicare reimbursement in investor-driven acquisition of for-profit hospices, comparing them with nonacquired hospices. Certain PE firms & PTCs showed reductions in care intensity. healthaffairs.org/doi/10.1377/hl…


